Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B10 pseudogene 1 (NDUFB10P1)

Target
NDUFB10P1
Molecular classification
Pseudogene, Processed pseudogene (retrocopy)
01

Overview

NDUFB10P1 is a processed pseudogene (also termed a retrocopy) of the functional NDUFB10 gene, which encodes a subunit of mitochondrial complex I. As a pseudogene, NDUFB10P1 harbors gene-disabling mutations and lacks regulatory elements required for normal transcription and translation, resulting in no protein product[5][2]. Pseudogenes can sometimes regulate parent gene expression at the RNA level and may serve as evolutionary markers or, rarely, have novel regulatory roles. However, NDUFB10P1 itself is not associated with any known direct biological function, disease, or therapeutic relevance[2][5][1].

Other names
NDUFB10P1100128711 (NCBI Gene)
02

Mechanism of action

Not applicable (does not encode a protein, lacks known druggable function)

03

Biological functions

May play roles in gene regulation, especially post-transcriptionally (e.g. via RNA mechanisms such as competing endogenous RNA)Genomic marker of evolutionary events
04

Disease associations

None directly established; pseudogenes like NDUFB10P1 may occasionally impact disease indirectly by regulatory interactions, but no specific role is assigned
05

Safety considerations

None (no known safety or therapeutic challenges as it is not drug-targeted)
06

Interacting drugs

None documented; pseudogenes generally do not have direct drug interactions
07

Biomarkers

None established; pseudogenes are sometimes explored as biomarkers but no reports for NDUFB10P1 specifically

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B10 pseudogene 1 (NDUFB10P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B10 pseudogene 1 (NDUFB10P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call